Diabetes and ischaemic stroke often arise together. People with diabetes have more than
double the risk of ischaemic stroke after correction for other risk factors, relative to individuals …

Background Alpha‐glucosidase inhibitors such as acarbose or miglitol, have the potential to
improve glycemic control in type 2 diabetes mellitus. The true value of these agents, …

Diabetes mellitus is associated with an increase in the risk of dementia and the proportion
of patients who convert from mild cognitive impairment (MCI) to dementia. In addition to MCI …

Background . Clinical data on the association of diabetes mellitus with common infections
are virtually lacking, not conclusive, and often biased. We intended to determine the relative …

OBJECTIVE— To estimate the health-related quality of life (HRQOL) and treatment
satisfaction for patients with type 2 diabetes in the Netherlands and to examine which patient …

Background Progressive β‐cell failure is a characteristic feature of type 2 diabetes;
consequently, β‐cell secretagogues are useful for achieving sufficient glycaemic control. The …

Background Intensive treatment of multiple cardiovascular risk factors can halve mortality
among people with established type 2 diabetes. We investigated the effect of early …

Aims/hypothesis The aim of this study was to assess the prevalence of (unknown) heart failure
and left ventricular dysfunction in older patients with type 2 diabetes. Methods In total, 605 …

OBJECTIVE To estimate the benefits of screening and early treatment of type 2 diabetes
compared with no screening and late treatment using a simulation model with data from the …

Context A recent overview of all CVD models applicable to diabetes patients is not available.
Objective To review the primary prevention studies that focused on the development, …